As more Americans return to pre-COVID-19 life and are taking fewer precautions, viruses such as respiratory syncytial virus (RSV) are on the rise. Health authorities and medical professionals are seeing an “unseasonably high number of RSV cases,” which are generally more common during the fall and winter seasons. High-risk babies are often given a monoclonal antibody treatment during the respiratory season as a prevention method, and use of the prophylaxis has increased in response to the rise in cases. “Those kids were being protected,” said Kristina Deeter, M.D., a pediatric intensivist and medical director at Renown Children’s Hospital Pediatric Intensive Care and Hospitalist Medicine in Reno, Nevada. Dr. Deeter, who also oversees Pediatrix Medical Group’s critical-care team in dozens of pediatric intensive care units across the country, said hospitals may take further precautions in the neonatal intensive-care unit like some wintertime protocols. 

View the full story at The Wall Street Journal (subscriber-only content)  

Find a Clinician Find a Practice Request for Proposal